×
Entrez Id: 1316
Gene Symbol: KLF6
KLF6
Prostatic Neoplasms
0.400
Biomarker
CTD_human
×
Entrez Id: 4601
Gene Symbol: MXI1
MXI1
Prostatic Neoplasms
0.360
Biomarker
CTD_human
×
Entrez Id: 8379
Gene Symbol: MAD1L1
MAD1L1
Prostatic Neoplasms
0.300
Biomarker
CTD_human
×
Entrez Id: 2346
Gene Symbol: FOLH1
FOLH1
Prostatic Neoplasms
0.400
Biomarker
CTD_human
1alpha,25-Dihydroxyvitamin D3 down-regulates expression of prostate specific membrane antigen in prostate cancer cells.
18247401 2008
×
Entrez Id: 6716
Gene Symbol: SRD5A2
SRD5A2
Prostatic Neoplasms
0.400
Biomarker
CTD_human
5alpha-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia.
17136762 2007
×
Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Prostate tumors induced by the deletion of Apc have elevated levels of beta-catenin protein and are highly proliferative.17363566 2007
×
Entrez Id: 857
Gene Symbol: CAV1
CAV1
Prostatic Neoplasms
0.400
Biomarker
CTD_human
CAV-1 is located within the prostate cancer aggressiveness locus at 7q31-33, and was identified as being overexpressed in prostate tumors .15948133 2005
×
Entrez Id: 463
Gene Symbol: ZFHX3
ZFHX3
Prostatic Neoplasms
0.330
Biomarker
CTD_human
ATBF1 has been recently identified as a candidate prostate tumor suppressor gene.16637072 2006
×
Entrez Id: 3925
Gene Symbol: STMN1
STMN1
Prostatic Neoplasms
0.320
Biomarker
CTD_human
Stathmin levels increase early during normal mouse prostate development and again during prostate tumor development and progression.17455228 2007
×
Entrez Id: 7113
Gene Symbol: TMPRSS2
TMPRSS2
Prostatic Neoplasms
0.400
Biomarker
CTD_human
TMPRSS2 -ERG (T2E) structural rearrangements typify ∼50% of prostate tumors and result in overexpression of the ERG transcription factor.28783165 2017
×
Entrez Id: 7040
Gene Symbol: TGFB1
TGFB1
Prostatic Neoplasms
0.400
Biomarker
CTD_human
A gain of function TGFB1 polymorphism may be associated with late stage prostate cancer.
15159307 2004
×
Entrez Id: 7157
Gene Symbol: TP53
TP53
Prostatic Neoplasms
0.400
Biomarker
CTD_human
A germline variant in the TP53 polyadenylation signal confers cancer susceptibility.
21946351 2011
×
Entrez Id: 10481
Gene Symbol: HOXB13
HOXB13
Prostatic Neoplasms
0.380
Biomarker
CTD_human
A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding.
24390282 2014
×
Entrez Id: 5728
Gene Symbol: PTEN
PTEN
Prostatic Neoplasms
0.600
Biomarker
CTD_human
A single-copy Sleeping Beauty transposon mutagenesis screen identifies new PTEN-cooperating tumor suppressor genes.
28319090 2017
×
Entrez Id: 56288
Gene Symbol: PARD3
PARD3
Prostatic Neoplasms
0.310
Biomarker
CTD_human
A single-copy Sleeping Beauty transposon mutagenesis screen identifies new PTEN-cooperating tumor suppressor genes.
28319090 2017
×
Entrez Id: 51322
Gene Symbol: WAC
WAC
Prostatic Neoplasms
0.300
Biomarker
CTD_human
A single-copy Sleeping Beauty transposon mutagenesis screen identifies new PTEN-cooperating tumor suppressor genes.
28319090 2017
×
Entrez Id: 11214
Gene Symbol: AKAP13
AKAP13
Prostatic Neoplasms
0.300
Biomarker
CTD_human
A single-copy Sleeping Beauty transposon mutagenesis screen identifies new PTEN-cooperating tumor suppressor genes.
28319090 2017
×
Entrez Id: 26137
Gene Symbol: ZBTB20
ZBTB20
Prostatic Neoplasms
0.300
Biomarker
CTD_human
A single-copy Sleeping Beauty transposon mutagenesis screen identifies new PTEN-cooperating tumor suppressor genes.
28319090 2017
×
Entrez Id: 10659
Gene Symbol: CELF2
CELF2
Prostatic Neoplasms
0.300
Biomarker
CTD_human
A single-copy Sleeping Beauty transposon mutagenesis screen identifies new PTEN-cooperating tumor suppressor genes.
28319090 2017
×
Entrez Id: 10481
Gene Symbol: HOXB13
HOXB13
Prostatic Neoplasms
0.380
Biomarker
CTD_human
A study based on whole-genome sequencing yields a rare variant at 8q24 associated with prostate cancer.
23104005 2012
×
Entrez Id: 5728
Gene Symbol: PTEN
PTEN
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate.
19396168 2009
×
Entrez Id: 2078
Gene Symbol: ERG
ERG
Prostatic Neoplasms
0.400
Biomarker
CTD_human
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate.
19396168 2009
×
Entrez Id: 10
Gene Symbol: NAT2
NAT2
Prostatic Neoplasms
0.330
Biomarker
CTD_human
Acetylation genotype and the genetic susceptibility to prostate cancer in a southern European population.
15717312 2005
×
Entrez Id: 5160
Gene Symbol: PDHA1
PDHA1
Prostatic Neoplasms
0.310
Biomarker
CTD_human
Additionally, we found that PDHA1 and the PDC activator pyruvate dehydrogenase phosphatase 1 (PDP1) are frequently amplified and overexpressed at both the gene and protein levels in prostate tumors .
29335542 2018
×
Entrez Id: 54704
Gene Symbol: PDP1
PDP1
Prostatic Neoplasms
0.310
Biomarker
CTD_human
Additionally, we found that PDHA1 and the PDC activator pyruvate dehydrogenase phosphatase 1 (PDP1 ) are frequently amplified and overexpressed at both the gene and protein levels in prostate tumors .
29335542 2018